Neurocrine Biosciences presents real-world evidence on classic congenital adrenal hyperplasia
The company presented evidence mapping the lifelong, evolving impact of classic congenital adrenal hyperplasia.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
The company presented evidence mapping the lifelong, evolving impact of classic congenital adrenal hyperplasia.